Get it in writing. That’s the moral in a pair of retractions in different journals after authors claimed to have received oral — but not written — ethics approval for their research.
One paper, in the International Journal of Pediatrics, a Hindawi title, came from a group in Kuwait and Greece. Titled “Prevalence and associated factors of peer victimization (bullying) among grades 7 and 8 middle school students in Kuwait, the article appeared in February 2017.
Researchers in Norway have retracted a second high-profile exercise paper — again after running afoul of an ethical approval committee.
As part of the 2016 study, the researchers gave athletes asthma medication to measure its effect on signals from the nervous system to the lungs; although the drug appeared to have no detectable effect on the nervous system signals, 45 minutes after getting the drug, athletes (including those without asthma) showed an average slight increase in one measure of lung function.
Annette Birkeland, of The Norwegian National Research Ethics Committees (FEK), told us:
An anatomy journal has banned a researcher from submitting papers for three years after determining one of his recently published papers suffered from “serious ethical” issues.
According to Jae Seung Kang, associate editor at the journal Anatomy and Cell Biology (ACB), the paper’s sole author—Jae Chul Lee—falsified both his affiliation and approval for conducting animal experiments in the paper, published online in March.
Here’s a head-scratcher: A 2017 paper examining why long space flights can cause eye damage has been taken down, with a brief note saying NASA, which sponsored the research, asked for the retraction because of “security concerns.”
According to the first author, the paper included information that could identify some of the astronauts that took part in the study — namely, their flight information. Although the author said he removed the identifying information after the paper was online, NASA still opted to retract it. But a spokesperson at NASA told us the agency did not supply the language for the retraction notice. The journal editor confirmed the paper was retracted for “research subject confidentiality issues,” but referred a question about who supplied the language of the notice back to NASA.
Now lawyers are involved.
So we still have some questions about this one. Here’s what we do know.
A journal has retracted a recent case report about a stem cell therapy in a child with cerebral palsy, after discovering the study failed to meet “ethical standards.”
According to the journal, Regenerative Medicine, the ethical issue is that the authors failed to report the case to the Ministry of Health, Labor and Welfare of Japan, which violates the country’s guidelines for conducting stem cell research. Unfortunately, we don’t know much more than that about what happened.
Psychiatry journals have retracted two papers evaluating a schizophrenia drug after a university in Japan flagged issues, such as a lack of written informed consent.
The papers—published in Human Psychopharmacology: Clinical & Experimental in 2012 and Psychiatry and Clinical Neurosciences in 2014—examined the safety and effectiveness of an antipsychotic drug in patients with schizophrenia.
According to the retraction notice in Psychiatry and Clinical Neurosciences, the ethics committee at St. Marianna University School of Medicine in Kawasaki found that “the trial included subjects who did not satisfy inclusion criteria.” For instance, not all patients provided written informed consent. But the university found no evidence for data falsification or fabrication.
An exercise scientist who ran a study of the CrossFit exercise program without an approved human subjects protocol has lost two more papers to retraction.
Both papers were retracted on June 26 by the editors of the International Journal of Exercise Science (IJES) with the agreement of last author Steven Devor, a former professor at The Ohio State University. Both have been retracted because the studies were carried out without proper IRB approval.
Only one of the newly retracted papers had anything to do with the CrossFit study: Published in April 2014, this paper suggested that the so-called “paleo” diet — a diet focused on meat and vegetables — is associated with “unfavorable” changes in cholesterols and other blood-based cardiovascular biomarkers. In addition to following the diet, subjects also participated in a CrossFit exercise program.Continue reading Researcher who tangled with CrossFit loses two more papers